MB-6
/ Microbio
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 22, 2020
A Trial of MB-6 for Reduction of Neutropenia Induced by Chemotherapy in Patients With Stage III Colorectal Cancer.
(clinicaltrials.gov)
- P=N/A; N=184; Recruiting; Sponsor: Microbio Co Ltd; Trial completion date: Mar 2019 ➔ Dec 2022; Trial primary completion date: Dec 2018 ➔ Mar 2022
Clinical • Trial completion date • Trial primary completion date • Colorectal Adenocarcinoma • Colorectal Cancer • Gastrointestinal Cancer • Hematological Disorders • Neutropenia • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1